Intersect ENT Inc (NASDAQ:XENT)

41.00
Delayed Data
As of Apr 23
 -0.75 / -1.80%
Today’s Change
17.25
Today|||52-Week Range
42.25
+26.54%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close41.75
Today’s open41.80
Day’s range40.85 - 42.01
Volume177,572
Average volume (3 months)253,330
Market cap$1.1B
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+37.08%
Earnings growth (this year)-4.87%
Earnings growth (next 5 years)-18.10%
Revenue growth (last year)+22.35%
P/E ratioNM
Price/Sales9.80
Price/Book9.56

Competitors

 Today’s
change
Today’s
% change
LMNXLuminex Corp-0.03-0.14%
CSIICardiovascular Syste...-0.02-0.09%
KTWOK2M Group Holdings I...+0.07+0.36%
ANIKAnika Therapeutics I...-0.32-0.71%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$96.3M
Annual profit (last year)-$16.4M
Net profit margin-16.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts